PremiumCompany AnnouncementsMaxCyte Announces Change in Major Shareholder Voting Rights MaxCyte Announces Change in Major Holdings by BlackRock BlackRock Increases Stake in MaxCyte, Boosting Voting Rights PremiumRatingsMaxCyte’s Strategic Growth and Stability: A Buy Rating by Analyst Mark Massaro MaxCyte’s Strong Financial Performance and Growth Potential Justify Buy Rating MaxCyte’s Strong Execution and Strategic Measures Earns Buy Rating Amid Market Challenges PremiumCompany AnnouncementsBlackRock Adjusts Stake in MaxCyte, Inc. MaxCyte Announces Change in Major Shareholder Holdings MaxCyte Announces Change in Major Holdings by BlackRock